Anavex Life Sciences Corp... (AVXL)

AI Score

Unlock

9.40

-0.05 (-0.53%)

At close: Apr 25, 2025, 3:59 PM

9.52

1.28%

After-hours: Apr 25, 2025, 05:34 PM EDT

Anavex Life Sciences Cash Flow Statement

Financials in USD. Fiscal year is October - September.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016	Dec 31, 2015
Net Income	-12.11M	-11.62M	-12.21M	-10.55M	-8.62M	-10.15M	-11.28M	-13.11M	-12.97M	-14.29M	-12.37M	-10.44M	-10.88M	-11.72M	-10.18M	-8.16M	-7.86M	-5.97M	-6.49M	-7.24M	-6.59M	-3.88M	-7.07M	-8.01M	-7.33M	-5.79M	-2.85M	-4.75M	-4.06M	-5.15M	-3.61M	-1.55M	-3.15M	-6.51M	-2.24M	-2.03M	-3.95M
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	506.00	249.00	248.00	249.00
Stock-Based Compensation	2.06M	2.01M	2.49M	2.65M	2.29M	3.19M	3.87M	3.97M	5.35M	6.04M	3.99M	4.44M	3.91M	3.15M	2.29M	1.85M	939.31K	660.6K	1.25M	1.7M	1.26M	1.24M	1.23M	1.89M	2.07M	1.49M	1.68M	1.23M	1.12M	1.12M	1.16M	968.89K	889.27K	3.79M	228.26K	222.69K	826.02K
Other Working Capital	3M	-2.45M	2.71M	-2.96M	30K	940.32K	1.89M	-1.19M	367.47K	3.51M	830.23K	-1.64M	3.58M	328.62K	-153.38K	-448.88K	-1.18M	-959K	860.8K	-249.18K	-1.82K	73.2K	-1.66M	1.78M	1.11M	248.29K	-916.7K	705.36K	-682.95K	1.84M	-448.41K	-117.55K	-896.23K	152.32M	-211.71K	50.9K	-117.22K
Other Non-Cash Items	n/a	59K	-59K	3.45M	3.16M	500.00	3.42M	845K	4.78M	1.98M	3.58M	7.54M	249.09K	3.12M	3.05M	1.85M	227.89K	8.85K	330.47K	522.24K	-395.83K	35.38K	-2.17M	1.35M	1.08M	413.5K	-207.67K	618.26K	-785.86K	2.13M	-75.2K	-75.05K	-995.58K	4.66K	8.00	-148.5K	-1.73K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-60.79K	-258	2.91K	n/a
Change in Working Capital	-2.06M	2.89M	4.61M	-3.76M	-982K	1.11M	-239.34K	-197K	1.83M	4.2M	1.33M	-3.64M	3.47M	891.69K	365.27K	-1.01M	-955.63K	-950.15K	1.19M	273.05K	-397.66K	73.2K	-1.66M	1.78M	1.11M	248.29K	-916.7K	705.36K	-682.95K	1.84M	-448.41K	-117.55K	-896.23K	918.09K	-211.71K	50.9K	-117.22K
Operating Cash Flow	-12.12M	-6.66M	-5.18M	-11.66M	-7.32M	-5.85M	-7.65M	-8.49M	-5.79M	-4.04M	-7.05M	-9.64M	-3.5M	-7.67M	-7.52M	-7.32M	-7.87M	-6.25M	-4.04M	-5.26M	-5.73M	-2.53M	-7.5M	-4.33M	-4.16M	-4.05M	-2.09M	-2.82M	-3.62M	-2.19M	-2.97M	-697.74K	-3.15M	-1.86M	-2.22M	-1.9M	-3.25M
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-34.76K	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	708K	89K	444K	7.28M	59K	868.34K	n/a	181.5K	-243	-75	327.91K	-251.3K	226.78K	2.22M	-2.06M	127.56K	-263.46K	-379.26K	-24.51K	n/a	n/a	n/a	n/a	n/a	-50K	-51.13K	-19.06K	-30.94K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-125.06K	125.06K
Financial Cash Flow	708K	89K	4.55M	7.28M	59K	2.06M	9M	18.33M	258.24K	2.44K	6.91M	11.84M	2.54M	2.22M	89.22M	35.82M	25.98M	7.88M	5.1M	4.37M	11M	3.47M	9.29M	3.07M	1.94M	1.16M	2.26M	428.91K	4.23M	4.84M	4.42M	2.89M	15.13M	1.32M	n/a	-1	1.81M
Net Cash Flow	-11.41M	-6.57M	-630K	-4.38M	-7.26M	-3.79M	1.35M	9.85M	-5.54M	-4.04M	-143.2K	2.2M	-961.39K	-5.45M	81.7M	28.5M	18.11M	1.63M	1.06M	-895.35K	5.27M	936.42K	1.79M	-1.26M	-2.22M	-2.9M	171.01K	-2.39M	608.39K	2.65M	1.44M	2.19M	11.97M	-540.23K	-2.22M	-1.9M	-1.44M
Free Cash Flow	-12.12M	-6.66M	-5.18M	-11.66M	-7.32M	-5.85M	-7.65M	-8.49M	-5.79M	-4.04M	-7.05M	-9.64M	-3.5M	-7.67M	-7.52M	-7.32M	-7.87M	-6.25M	-4.04M	-5.26M	-5.73M	-2.53M	-7.5M	-4.33M	-4.16M	-4.05M	-2.09M	-2.82M	-3.62M	-2.19M	-2.97M	-697.74K	-3.15M	-1.86M	-2.22M	-1.9M	-3.25M